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Study Objective. To evaluate the effect of cardiac arrest and cardiopulmonary
resuscitation (CPR) on blood chemistry in a canine model.
Design. Evaluative canine animal study. 
Setting. Animal laboratory accredited by the Association for Assessment and
Accreditation of Laboratory Animals.
Subjects. Twenty-six adult mongrel dogs.
Intervention. The dogs underwent an episode of induced fibrillatory cardiac
arrest for 3 minutes followed by 10 minutes of standard CPR.  Blood
samples were taken at baseline (before cardiac arrest), after 10 minutes of
ventricular fibrillation, and 10 minutes after successful resuscitation for
determination of blood chemistries and hematologic parameters.
Measurements and Main Results. Glucose, blood urea nitrogen, serum
creatinine, sodium, potassium, chloride, calcium, phosphorus, uric acid,
alkaline phosphatase, lactate dehydrogenase, aspartate aminotransferase,
alanine aminotransferase, protein, albumin, cholesterol, triglycerides, iron,
white blood cell count, red blood cell count, and hematocrit were
measured.  Significant changes (p<0.05) in values obtained during CPR
versus baseline values were noted for all laboratory parameters except
blood urea nitrogen, chloride, and alkaline phosphatase.  Eighteen dogs
achieved return of spontaneous circulation (ROSC); their laboratory values
were obtained after CPR.  Significant changes (p<0.05) after ROSC
compared with baseline were noted for all laboratory values except
chloride, blood urea nitrogen, uric acid, alkaline phosphatase, glucose,
potassium, calcium, triglycerides, iron, red blood cell count, and
hematocrit.
Conclusion. Results indicate that significant changes in blood chemistries
and hematologic parameters occur during and after CPR.  Clinicians should
note these normal laboratory parameter changes when interpreting
laboratory data in patients who experience cardiac arrest.
(Pharmacotherapy 2001;21(10):1187–1191)
Cardiac arrest results in cessation of
circulation, and cardiopulmonary resuscitation
(CPR) only partially restores circulation of blood.
Hence, compromised blood circulation persists
until return of spontaneous circulation (ROSC) is
achieved.1
Acute alterations to circulation of blood—from
no flow (at the time of cardiac arrest) to partial
flow (during CPR), and finally to ROSC—can
alter acid-base and biochemical parameters.1–3
However, these effects on overall blood chemistry
and hematologic parameters are not well
described.  Previous studies have either evaluated
a limited number of biochemical parameters4 or
examined overall blood chemistry at time points
considerably beyond the acute CPR phase.5
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Without an appreciation of normal chemical and
hematologic derangements that occur during and
after cardiac arrest, researchers and health care
providers cannot adequately evaluate laboratory
data in an animal study involving drugs that may
alter electrolyte or hematologic parameters, or in
an individual patient with cardiac arrest.
Since animal cardiac arrest models are well
established and often used to evaluate potential
interventions in cardiac arrest, we evaluated the
effect of cardiac arrest with CPR after ROSC on
laboratory parameters in dogs.  To our
knowledge, no study has evaluated alterations in
overall blood chemistry and hematologic
parameters during CPR.
Methods
Laboratory data for 26 adult mongrel dogs
(weight 12–16 kg) were collected from two
separate studies of cardiac arrest and CPR.  Use
of these dogs was approved by the Animal Care
Institutional Review Committee of Hartford
Hospital, Hartford, Connecticut, and the animal
laboratory was accredited by the Association for
Assessment and Accreditation of Laboratory
Animals.  In both studies, dogs were anesthetized
with thiopental 20 mg/kg followed by a-
chloralose 70 mg/kg.  They were secured in
supine position on a surgical table with a
thermoblanket to maintain 37°C body
temperature.  A cuffed endotracheal tube was
placed, and the dogs were ventilated by respirator
(Harvard volume respirator model 613) at 10
breaths/minute.  At baseline, blood gases were
stabilized to an arterial blood pH level of 7.40 ±
0.05 and a partial pressure of carbon dioxide
level of 40 ± 5 mm Hg with adjustments of tidal
volume and/or administration of sodium
bicarbonate as required.
Throughout the study, aortic, left ventricular,
and right atrial pressures were measured
continuously after proper catheterization, and
electrocardiogram readings were taken
continuously.  All animals received heparin 150
U/kg periodically to maintain catheter patency.
The study involved induction of ventricular
fibrillation, CPR, and then defibrillation using
the same methods.  Ventricular fibrillation was
induced with 80 mA of electrical current through
a coronary pacing catheter.  After 3 minutes of
ventricular fibrillation without ventilation, CPR
was performed with a pneumonic chest
compression device (Thumper, Michigan
Instruments, Grand Rapids, MI) for 10 minutes.
The device was set to compress the chest 60
times/minute with a compression duration of 0.5
seconds.  Compression force was set to produce
an initial coronary perfusion pressure gradient of
20 mm Hg and was maintained throughout the
CPR period (perfusion pressure gradient was
determined by subtracting left-ventricular mid-
diastolic pressure from aortic pressure).  After
every fifth compression, diastole was prolonged
by 0.5 seconds and the lungs were inflated to an
inspiratory pressure of approximately 10 cm of
water (with 100% oxygen) by a synchronized
pressure-limited ventilator.
Aortic blood samples were obtained 58
minutes before ventricular fibrillation, after 8–12
minutes of ventricular fibrillation, and at 10
minutes after ROSC.  Glucose, blood urea
nitrogen (BUN), serum creatinine (Scr), sodium,
potassium, chloride, calcium, phosphorus, uric
acid, alkaline phosphatase, lactate dehydrogenase
(LDH), aspartate aminotransferase (AST), alanine
aminotransferase (ALT), protein, albumin,
cholesterol, triglycerides, and iron (American
Monitor Parallel Analyzer, American Monitor,
New York, NY) were measured.  We also obtained
white blood cell count, red blood cell count, and
hematocrit (H-6000 Auto Analyzer, Technon
Instruments, Austin, TX).
Data Analysis
Laboratory values (expressed as mean ± SD) at
baseline, during CPR, and after ROSC were
compared using analysis of variance (ANOVA).
If ANOVA demonstrated a significant difference,
then the t test with Bonferroni correction was
used to determine which group(s) were
significantly different.  A p value less than or
equal to 0.05 was considered significant.
Results
Of the 26 dogs undergoing CPR, 18 achieved
ROSC.  Table 1 shows the laboratory values
observed at each stage of our study.  Table 2
shows changes during CPR and after ROSC
versus baseline values.  When ANOVA was used
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to compare each laboratory parameter for the
three stages (baseline, during CPR, and after
ROSC), significant differences were found for all
except BUN, chloride, alkaline phosphatase, iron,
and white blood cell count concentrations.
Values for the CPR period differed significantly
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Table 1.  Laboratory Values Observed at Each Stage of Study (baseline, CPR, ROSC)
Reference Baseline During CPR After ROSC
Laboratory Parameter Limit (n=26) (n=26) (n=18)
Glucose (mg/dl) 75–110 108 ± 33.8 232 ± 86.0a 219 ± 67.2a
Blood urea nitrogen (mg/dl) 7–25 12.6 ± 4.2 12.8 ± 4.8 13.5 ± 5.5
Creatinine (mg/dl) 0.7–1.7 0.84 ± 0.10 0.93 ± 0.12a 1.08 ± 0.13a, b
Sodium (mEq/L) 135–145 148 ± 3.9 144 ± 4.1a 151 ± 4.0a
Potassium (mEq/L) 3.2–5.0 3.4 ± 0.4 4.4 ± 0.49a 3.8 ± 0.53a, b
Chloride (mEq/L) 97–111 115 ± 3.1 115.6 ± 3.2 115.7 ± 3.1
Calcium (mg/dl) 8.8–10.3 9.2 ± 0.4 8.5 ± 0.4a 8.4 ± 0.4a
Phosphorus (mg/dl) 2.5–4.5 5.1 ± 0.7 5.7 ± 0.79a 6.9 ± 1.1a, b
Uric acid (mg/dl) 2–9 0.9 ± 0.3 2.5 ± 1.1a 0.6 ± 0.4
Alkaline phosphatase (U/L) 25–100 38.7 ± 13.2 47.3 ± 22.6 49.5 ± 23.1
Lactate dehydrogenase (U/L) 100–300 118 ± 53 184 ± 94.3a 254 ± 104.3a, b
Aspartate aminotransferase (U/L) 5–30 38.3 ± 12.4 115.7 ± 28.1a 223.7 ± 69.1a, b
Alanine aminotransferase (U/L) 5–30 28.0 ± 15.5 101.1 ± 63.9a 221.8 ± 129.1a, b
Protein (g/dl) 6.3–8.4 4.5 ± 0.7 3.9 ± 0.8a 3.4 ± 0.8a
Albumin (g/L) 3.7–5.2 2.2 ± 0.3 1.9 ± 0.4 1.65 ± 0.4b
Total cholesterol (mg/dl) 100–245 104 ± 30 82 ± 37.1a 80 ± 38.2a
Triglycerides (mg/dl) 40–180 26 ± 9.5 45 ± 26.7a 26.6 ± 16.0b
Iron (µg/dl) 60–150 99.9 ± 30.4 83.0 ± 39.9 85.2 ± 40.1
White blood cell count (x 103/mm3) 4.8–10.0 5.3 ± 3.4 7.3 ± 4.8 6.9 ± 5.3
Red blood cell count (x 106/mm3) 4.6–6.2 5.1 ± 0.7 6.3 ± 1.0a 5.5 ± 0.8b
Hematocrit (%) 40–54 35.2 ± 4.5 39.6 ± 5.1a 37.7 ± 5.4
CPR = cardiopulmonary resuscitation; ROSC = return of spontaneous circulation.
aSignificant difference from baseline (p<0.05).
bSignificant difference between CPR and post-CPR periods (p<0.05).
Table 2.  Changes in Laboratory Parameters during CPR and after ROSC versus Baseline
Values
Laboratory % Change during CPR % Change after ROSC
Parameter (n=26) (n=18)
Glucose (mg/dl) › 115 ± 86a › 103 ± 98.7
Blood urea nitrogen (mg/dl) › 1.4 ± 14.0 › 7.0 ± 30.0
Creatinine (mg/dl) › 11.3 ± 16.9a › 29.0 ± 35.4a
Sodium (mEq/L) fl 2.7 ± 4.4a › 1.8 ± 4.2a
Potassium (mEq/L) › 30.0 ± 22.0a › 12.3 ± 32.3b
Chloride (mEq/L) › 0.5 ± 3.8 › 0.6 ± 4.0
Calcium (mg/dl) fl 7.6 ± 6.4a fl 8.2 ± 6.7
Phosphorus (mg/dl) › 12.5 ± 13.0a › 35.5 ± 60.1a
Uric acid (mg/dl) › 183 ± 279a fl 333 ± 418
Alkaline phosphatase (U/L) › 22.1 ± 71.0 › 28.0 ± 75.0
Lactate dehydrogenase (U/L) › 56.0 ± 78.0a › 115.0 ± 96.8a, b
Aspartate aminotransferase (U/L) › 202 ± 227a › 484 ± 557a, b
Alanine aminotransferase (U/L) › 261 ± 312a › 692 ± 733a, b
Protein (g/L) fl 14.3 ± 20.0a fl 25.2 ± 20.5a
Albumin (g/dl) fl 15.9 ± 17.0a fl 25.2 ± 20.9a
Total cholesterol (mg/dl) fl 16.4 ± 23.6a fl 23.2 ± 27.4a
Triglycerides (mg/dl) › 72.7 ± 181a › 2.3 ± 68.6
Iron (µg/dl) fl 16.9 ± 31.3a fl 14.7 ± 32.0
White blood cell count (x 103/mm3) › 37.4 ± 42.0a › 29.3 ± 55.7a
Red blood cell count (x 106/mm3) › 24.3 ± 48.3a › 6.9 ± 19.7
Hematocrit (%) › 12.6 ± 14.1a › 7.0 ± 20.5
CPR = cardiopulmonary resuscitation; ROSC = return of spontaneous circulation.
aSignificant difference from baseline (p<0.05).
bSignificant difference between CPR and post-CPR periods (p<0.05).
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from those at baseline for all laboratory
parameters except BUN, chloride, alkaline
phosphatase, albumin, total cholesterol, iron, and
white blood cell counts.  When post-CPR data for
the 18 animals that achieved ROSC were
compared with baseline values, BUN, chloride,
uric acid, alkaline phosphatase, triglyceride, iron,
white blood cell count, red blood cell count, and
hematocrit levels were not significantly different.
Hence uric acid, triglyceride, red blood cell
count, and hematocrit levels changed
significantly during CPR from baseline values,
but changes that occurred in the post-CPR period
lost significance compared with baseline values.
Conversely, albumin and total cholesterol levels
did not change significantly during CPR but
changed significantly after ROSC.  Compared
with laboratory parameters obtained during CPR,
potassium, triglycerides, red blood cell count,
and hematocrit levels were significantly lower
after ROSC, whereas liver transaminases (LDH,
AST, ALT), creatinine, and phosphorus were
significantly higher after ROSC.
Discussion
Significant changes for most chemical and
hematologic parameters occur during cardiac
arrest with CPR compared with baseline values.
Similarly, changes induced during CPR are
generally maintained 10 minutes after ROSC for
most parameters.
Potassium levels after ROSC were significantly
lower than during CPR.  The potassium increase
during cardiac arrest and CPR may be due to an
extracellular shift of potassium by ventricular
fibrillation-induced acidosis.  Similarly, after
ROSC, acidosis theoretically would be abolished
and potassium would again shift intracellularly.
This initial increase in potassium during CPR
followed by a decrease toward normal after
successful ROSC has been described.6 In
addition, serum potassium increased from 3.7 ±
0.3 mEq/L at baseline to 3.9 ± 0.6 mEq/L 5
minutes after resuscitation in a study of cardiac
arrest in 30 adult mongrels.4 After the transient
increase in serum potassium concentration
occurred, concentrations decreased below
baseline value, achieving a nadir 45–60 minutes
after resuscitation.  These researchers suggested
that endogenous catecholamines could have
induced potassium release from the liver or that
tissue ischemia and trauma associated with chest
massage increased serum potassium concentrations.
Our study showed serum calcium concentrations
0.7 and 0.8 mg/dl lower than baseline values
during CPR and 10 minutes after ROSC,
respectively.  Likewise, the earlier study4
demonstrated serum calcium concentrations 0.7
mg/dl lower than baseline values both 5 and 15
minutes after resuscitation.  The researchers
hypothesized that since endogenous epinephrine
activates cellular calcium channels, the
decrement in serum calcium may have occurred
secondary to increased entry of calcium into
cells.  However, we also found a reduction in
circulating albumin concentrations.  Since
approximately 80% of circulating calcium is
bound to albumin, and the free calcium level is
important in physiologic processes, a correction
factor (corrected calcium = measured calcium +
0.8 [normal albumin – actual albumin]) was
used.7 Using baseline albumin as normal for
dogs, we calculated the corrected calcium
concentrations during CPR as 8.7 mg/dl and 10
minutes after ROSC as 8.8 mg/dl, which were still
less than the baseline value of 9.2 mg/dl.
In general, reductions in circulating albumin
concentrations are due to the combination of
three separate effects:  extravasation of albumin
into the extravascular compartment due to
increased capillary permeability to a new
equilibrium, downregulation of hepatic albumin
synthesis by actions of cytokines (tumor necrosis
factor, interleukin-1, and interleukin-6), and
increased albumin catabolism.8 In this very short
time from baseline to cardiac arrest and then
ROSC, the only factor that could account for this
effect would be a shift of more albumin out of the
vasculature and into the extracellular space.  This
mechanism has been the most rapid means of
albumin reduction in patients with other
conditions.8 Whether it explains the cholesterol
reductions observed in our study is not known. 
Conversely, results of liver transaminase
function tests (LDH, AST, ALT) were
significantly higher after than during CPR,
although values for both were significantly
higher than baseline values.  The increase in
transaminases after ROSC versus during CPR
may represent a washout phenomenon (e.g., liver
damage may be occurring primarily during
cardiac arrest, but blood flow is insufficient to
carry markers for liver injury into general
circulation for detection until ROSC is achieved).
Impairment of liver blood flow during cardiac
arrest and CPR has been demonstrated by our
research group and others.9, 10 This phenomenon
would be similar to that seen after thrombolytic
or primary angioplasty therapy during acute
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myocardial infarction for creatine kinase MB.11
Since the liver stores red blood cells, it may
lose some capacity to hold onto this blood
component during CPR, which could explain the
increase in both red blood cell count and
hematocrit.  However, the actual reason is not
known.
Study Limitations
Some limitations of data collected in this study
must be noted.  First, animal models have been
used as a surrogate for humans in advanced
cardiac life support research and provide
information on qualitative rather than
quantitative changes that could be expected.
Second, our model used a short duration of
cardiac arrest and CPR and therefore may not
apply to prolonged arrest situations.  Third, pH
was not continuously evaluated during the study;
if it had been, it may have further elucidated why
changes in other substances occurred. 
Clinical Implications
In light of our findings, clinicians should be
aware that blood chemistries and hematologic
parameters may change in animals and humans
during CPR.  Alterations of a specific parameter
could be due to cardiac arrest, rather than being a
cause or precipitant of arrhythmia.  For example,
if the serum potassium level during CPR is low-
normal (3.5–3.7 mEq/L) during cardiac arrest,
presence of hypokalemia (a potential contributor)
before the arrest cannot be ruled out.  Similarly,
appreciating that liver transaminases rise after
ROSC could be important.  Increased AST and
ALT levels observed in our study were 3–8 times
the upper limit of normal.  Administration of
intravenous amiodarone during and after cardiac
arrest could be valuable but should be stopped if
it causes liver toxicity.12 However, if increased
AST and ALT levels mistakenly are attributed to
amiodarone rather than considered a
consequence of cardiac arrest with CPR,
premature termination of amiodarone could put
patients at risk.  Furthermore, patients who need
other beneficial agents, such as 3-hydroxy-
methylglutaryl coenzyme A reductase inhibitors
or fibric acid derivatives, may not be given these
agents because of perceived (but actually
nonexistent) hepatic impairment.
Conclusion
Several chemical and hematologic parameters
change during cardiac arrest with CPR; others
change after ROSC.  Clinicians need to know
which parameters change during and after
cardiac arrest when they explore causative factors
regarding an arrhythmic event or a potential
subsequent problem.
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